|
HS Code |
540187 |
| Generic Name | Ceftizoxime Sodium |
| Drug Class | Third-generation cephalosporin antibiotic |
| Chemical Formula | C13H12N5NaO5S2 |
| Molecular Weight | 421.38 g/mol |
| Route Of Administration | Intravenous, Intramuscular |
| Indications | Bacterial infections including respiratory tract, urinary tract, skin, and intra-abdominal infections |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins |
| Spectrum Of Activity | Broad-spectrum against Gram-positive and Gram-negative bacteria |
| Contraindications | Known hypersensitivity to cephalosporins |
| Common Side Effects | Diarrhea, rash, nausea, injection site reactions |
| Storage Conditions | Store below 25°C, protected from light |
| Atc Code | J01DD08 |
As an accredited Ceftizoxime Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ceftizoxime Sodium packaging: Sealed glass vial, 1g powder for injection, labeled with product name, dosage, batch number, and expiration date. |
| Shipping | Ceftizoxime Sodium is shipped in tightly sealed, moisture-resistant containers under cool, dry conditions. It is typically packaged in compliance with international regulations for pharmaceuticals, ensuring protection from light and contamination. Handling precautions and documentation such as safety data sheets accompany each shipment to guarantee safe and compliant transportation. |
| Storage | Ceftizoxime Sodium should be stored in a tightly closed container, protected from light and moisture. It should be kept at a temperature between 2°C and 8°C (36°F and 46°F), and should not be frozen. The storage area must be well-ventilated and free from incompatible substances to maintain the chemical’s stability and effectiveness. |
|
Purity 98%: Ceftizoxime Sodium with a purity of 98% is used in hospital intravenous therapy, where it ensures rapid bacterial clearance in severe infections. Particle Size 10 µm: Ceftizoxime Sodium of 10 µm particle size is used in parenteral formulations, where it achieves optimal dissolution for consistent dosing. Stability Temperature 25°C: Ceftizoxime Sodium stable at 25°C is used in pharmaceutical storage, where it maintains efficacy during shelf-life. Water Solubility 200 mg/mL: Ceftizoxime Sodium with water solubility of 200 mg/mL is used in injectable solutions, where it allows for high-concentration mixing for acute infection management. Endotoxin Level < 0.5 EU/mg: Ceftizoxime Sodium with endotoxin level below 0.5 EU/mg is used in critical care settings, where it reduces risk of pyrogenic reactions during intravenous administration. Molecular Weight 467.44 g/mol: Ceftizoxime Sodium with a molecular weight of 467.44 g/mol is used in dose calculations for pediatric care, where it provides accurate therapeutic concentrations. |
Competitive Ceftizoxime Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Antibiotics have shaped modern medicine, offering hope and healing for infections that once posed life-threatening risks. Ceftizoxime Sodium, a third-generation cephalosporin, came onto the scene offering new possibilities, especially for doctors who need an option against stubborn bacterial infections. This product targets Gram-negative bacteria effectively and steps up where older drugs might fall short. From my experience working with healthcare professionals, it’s clear people rely on medicines like this when other options get complicated or show resistance.
In the world of antibiotics, not all medications punch at the same weight. Ceftizoxime Sodium brings a particular strength to the table. It shows up in the form of a sterile powder—white or off-white—with models featuring different dosages, typically ranging from 0.5g to 2g per vial. Hospitals and clinics prepare it for injection, mostly intravenous, sometimes intramuscular, depending on the infection and how quickly results are needed. Each batch gets tested to ensure the main ingredient—the sodium salt of ceftizoxime—delivers consistent results. Healthcare workers appreciate having several strengths to match different patient needs, especially children or those balancing other treatments.
Every day, hospitals face conditions like pneumonia, urinary tract infections, meningitis, skin infections, and abdominal infections. Ceftizoxime Sodium steps up in many of these cases. I remember seeing this antibiotic bring relief after other treatments lagged, especially in pneumonia or severe kidney infections. Its broad spectrum covers many bacteria, yet it manages to skip over most Gram-positive types, giving it a narrower—but valuable—focus. In some regions, doctors turn to this medication when tackling hospital-acquired infections, where resistance makes usual therapies unreliable.
Penicillin and the earlier cousins of cephalosporins can miss certain bacteria, especially the kind that outsmart beta-lactam drugs. Ceftizoxime Sodium changes things by binding to bacterial cell wall proteins, stopping bacteria from building up their walls, so they can’t multiply and keep infecting. Some drugs in the same family, like cefotaxime or ceftriaxone, work similarly but come with slightly different coverage and half-lives in the body. Ceftizoxime Sodium, in clinical reviews, stands out for fewer allergic responses and an ability to hit bacteria that other drugs don’t touch as effectively. I once heard an infectious disease expert highlight how a quick switch to Ceftizoxime pulled a patient out of a fever spiral when other options failed.
No discussion about modern antibiotics can avoid the topic of drug resistance. Instructions from the WHO and CDC stress careful selection, and Ceftizoxime Sodium plays into this with its own resistance profile. Many older antibiotics fall short as bacteria adapt, leaving doctors scrambling. Studies published in journals like the Journal of Chemotherapy point out that Ceftizoxime, while not invincible, gives an extra tool when dealing with bacteria like Enterobacteriaceae that have defeated simpler drugs. I’ve seen cases where switching to Ceftizoxime meant a faster recovery and a shorter hospital stay, reducing overall costs and complications. But it’s not a panacea—overuse will land this drug in the same trouble if stewardship lapses.
Cefotaxime and ceftriaxone both carry some similarities to Ceftizoxime Sodium, but practice shows key differences. Ceftriaxone offers a longer half-life, useful for outpatient therapy with one daily dose. Cefotaxime, on the other hand, needs more frequent dosing. Through several rounds of comparison, clinical voices note that Ceftizoxime often brings fewer side effects, especially in older adults or patients with kidney problems, since its metabolic pathway is more predictable. There’s a practical side: While ceftriaxone has some activity against Streptococcus pneumoniae, Ceftizoxime tilts more toward Gram-negative coverage like E. coli or Klebsiella. Nurses working with sick children often mention that Ceftizoxime’s dosing flexibility helps balance therapy in fragile scenarios.
Medicines don’t all arrive with the same standards. Reputable suppliers and manufacturers of Ceftizoxime Sodium use guidelines from pharmacopeias, and they show certificates of analysis, sterility, and potency with each batch. Habits from past experience tell me to always check for a clear solution after reconstitution; any cloudiness or particles mean there’s a problem with stability. While most brands use glass vials to avoid reactions with the powder, I’ve seen cheaper packaging lead to trouble in storage or transport. Given the global nature of supply chains, it matters a lot where and how each unit gets made, and whether cold chain or temperature monitoring kept quality intact on the journey to the end user.
In most clinics, Ceftizoxime Sodium lands in fridges set at 2-8°C, away from light and moisture. After mixing with sterile water, the solution must go into the patient quickly, typically within 24 hours. Nurses mention that staff must wear gloves to avoid skin sensitivity, and care must be taken not to mix it with solutions containing calcium (to avoid reactions in the line). Side effects rarely go beyond mild reactions—maybe a bit of soreness at the injection site or minor digestive upset—but allergy risk always lingers, especially for people who have reacted to other beta-lactams. I’ve seen best results when teams run a full history and stay close by for the first dose.
Not every infection suits Ceftizoxime Sodium. Anaerobic bacteria, and many Gram-positive strains, need different drugs. Some patients show up with chronic kidney disease—a big point, since the kidneys process and clear ceftizoxime. Dosage adjustments happen here, and monitoring for toxicity matters. Pregnant or breastfeeding women, on the other hand, usually rely on older cephalosporins with longer safety records; guidelines tend to limit Ceftizoxime for these groups until absolutely necessary. Most troubling, in rare cases, people respond with rashes, fever, or even more serious reactions like anaphylaxis. On occasion, abnormal blood tests signal bone marrow changes or liver effects—warnings that call for drug withdrawal and follow-up.
Cost and access shape how and where Ceftizoxime Sodium reaches people. Prices shift based on country, supplier, and whether it’s a generic or branded product. In some countries, public hospitals list it as an essential medicine for certain infections, while in other regions, high pricing or limited distributors force doctors to rely on less suitable drugs. My own contacts in small public hospitals say it helps to have Ceftizoxime when treating hospital outbreaks, as local bacteria sometimes resist most basic drugs. Health agencies sometimes step in to purchase stockpiles for emergencies, especially when outbreak patterns shift or new resistance emerges. Supply shortages, especially in rural areas, can erase those gains overnight.
The environmental story sits in the background, but it matters. Waste from antibiotics, including Ceftizoxime Sodium, can leak into water and soil—fuel for resistance in the wild. Hospitals and clinics juggle disposal rules, making sure leftover vials or used syringes head to designated incineration or hazardous waste. I once watched a colleague flag a box of expired antibiotics in the medication room; any shortcut in disposal threatens to tip the balance against us, strengthening bacteria out in the community. It takes a clinic-wide commitment to keep dangerous leftovers from doing harm, with education on safe storage and sharp attention to expired products.
Doctors don’t pick Ceftizoxime without thought. Local and international guidelines shape its use—where it fits, which infections, and which patient populations. Institutions often update protocols based on biannual data showing infection rates or new resistance patterns. I’ve seen multi-disciplinary rounds where infectious disease experts meet with pharmacists and nurses to weigh the benefits and risks for every patient. That shared discussion helps keep drug use in line with evidence and reduces harmful or reckless prescribing. Some countries use software to flag inappropriate use, but deep-down it comes back to individual professionals learning the importance of choosing wisely.
The world of antibiotics never stands still. Researchers study Ceftizoxime Sodium for new roles: treating combined infections, or probing how it performs in patients with complex medical backgrounds. Results from multi-center trials often reach the medical press, pointing out subtle benefits in groups like diabetic patients or people in intensive care. Some teams focus on finding the lowest effective dose to cut risks of toxicity or resistance. Pharmaceutical scientists also test new formulations, aiming to extend shelf life or make it possible to use in places without perfect refrigeration. While results range in strength, one thing stands out—no drug stays effective without regular research and adaption.
The antibiotic era faces real danger from resistance, cost issues, and gaps in supply—factors that touch Ceftizoxime Sodium along with every other antimicrobial. Global health agencies predict a grim curve in deaths from untreatable infections if no changes happen soon. Misuse for minor illness, like viral colds, fuels the march toward more superbugs. Watching this up close, it’s clear that each prescription counts, especially in smaller communities or crowded hospitals where new bugs circulate faster. Where Ceftizoxime Sodium is well-managed, care teams sometimes cut hospital stays, clear infections faster, and save lives. Still, it’s easy to see how overuse or the wrong dose will erase those gains.
Tackling resistance and improving access means education and accountability. Doctors and pharmacists need up-to-date data about which antibiotics work best in their area, including specifics on Ceftizoxime Sodium. I’ve seen programs where daily or weekly feedback on antibiotic use drives positive change, cutting unnecessary prescriptions by half. Hospitals get better results by tracking each patient’s progress and steering away from “just-in-case” dosing. Manufacturers have a role, too, refining production practices so quality stays high and environmental impacts shrink. Better packaging—think single-use vials and more robust storage—cuts down on waste and dosing errors.
Public health agencies can help by funding local labs to monitor which bacteria are causing illness, feeding that information back to clinicians for smarter choices. Governments should support education campaigns so both professionals and patients understand when antibiotics help and when they do not. In the clinics I’ve visited, only a handful of patients grasp the risk of antibiotic misuse; with the right messages, that changes quickly.
Ceftizoxime Sodium matters most where other tools stop working, offering hope in tough situations. It stands apart from older antibiotics for its coverage of hard-to-treat infections and a pattern of fewer adverse reactions in tricky cases. From busy emergency departments to resource-limited clinics, this drug provides an important middle ground between common antibacterials and the more toxic, last-resort options. Its story is tightly bound to how responsibly it gets used and how carefully people—doctors, nurses, pharmacists, and patients—pay attention to resistance and safety.
Success in fighting infections does not rest on a single drug but the entire system around it. Effective drugs like Ceftizoxime Sodium shine brightest in places committed to good science, patient safety, and open communication. Every vial used for the right patient, at the right time, brings another win for modern medicine, protecting these antibiotics for those who truly need them.